Details on Phase of the study 2.0 (pilot/pivotal/postmarketing clinical Yes investigation), Whether this study is a global clinical 3.0 investigation if yes, Number of sites and Yes patients as well as justification for undertaking such clinical investigation in India, Design analysis data as per Table 1 of 4.0 No schedule VII, Design input and design output 4.1 Yes documents,
4.2 Mechanical and electrical tests, Yes
4.3 Reliability tests, Yes
Validation of software relating to the
4.4 Yes function of the device,
4.5 Any performance test, Yes
4.6 Ex vivo tests, Yes
Biocompatibility and Animal
5.0 performance study for Investigational Yes medical device as per Table 2 of schedule VII, The agreement between the Sponsor 6.0 and Principal and coordinating Yes investigator, 7.0 Appropriate Insurance certificate, if any, No
Forms for reporting any adverse event
8.0 Yes and serious adverse event, Report of biocompatibility tests along 9.0 with rationale for selecting these tests Yes including a summary report and conclusion of the study,
10.0 Results of the risk analysis, Yes
11.0 Animal Performance study data, Yes
Investigators Brochure as per Table 4 of
12.0 Yes schedule VII, Clinical Investigational Plan as per Table 13.0 Yes 5 of schedule VII, Case Report Form as per Table 6 of 14.0 Yes schedule VII, Informed Consent Form as per Table 8 15.0 Yes of schedule VII, Undertaking by the Investigator as per 16.0 Yes Table 9 of schedule VII, Pilot or Pivotal Clinical Investigation 17.0 data, including that carried out in other No countries (if any), Regulatory status and Restriction on use 18.0 in other countires (if any) where No marketed or approved, 19.0 Proposed Instruction for use and labels, Yes
Ethics Committee Approval letter as per
20.0 format prescribed in APPENDIX VIII of Yes Schedule Y of Drugs and Cosmetics Act 1945,
Design Considerations and Pre Market Submission Recommendations For Interoperable Medical Devices - Guidance For Industry and Food and Drug Administration Staff